Repligen Statistics
Total Valuation
Repligen has a market cap or net worth of $9.63 billion. The enterprise value is $9.57 billion.
| Market Cap | 9.63B |
| Enterprise Value | 9.57B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Repligen has 56.29 million shares outstanding. The number of shares has increased by 0.53% in one year.
| Current Share Class | 56.29M |
| Shares Outstanding | 56.29M |
| Shares Change (YoY) | +0.53% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 107.43% |
| Float | 52.70M |
Valuation Ratios
The trailing PE ratio is 5,539.04 and the forward PE ratio is 88.67. Repligen's PEG ratio is 2.63.
| PE Ratio | 5,539.04 |
| Forward PE | 88.67 |
| PS Ratio | 13.57 |
| Forward PS | 11.86 |
| PB Ratio | 4.62 |
| P/TBV Ratio | 16.74 |
| P/FCF Ratio | 87.53 |
| P/OCF Ratio | 73.55 |
| PEG Ratio | 2.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.72, with an EV/FCF ratio of 86.99.
| EV / Earnings | 5,504.58 |
| EV / Sales | 13.51 |
| EV / EBITDA | 69.72 |
| EV / EBIT | 159.29 |
| EV / FCF | 86.99 |
Financial Position
The company has a current ratio of 8.36, with a Debt / Equity ratio of 0.33.
| Current Ratio | 8.36 |
| Quick Ratio | 6.85 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 4.15 |
| Debt / FCF | 6.26 |
| Interest Coverage | 2.60 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on invested capital (ROIC) is 1.37%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 1.30% |
| Return on Invested Capital (ROIC) | 1.37% |
| Return on Capital Employed (ROCE) | 2.15% |
| Revenue Per Employee | $398,138 |
| Profits Per Employee | $978 |
| Employee Count | 1,778 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, Repligen has paid $2.92 million in taxes.
| Income Tax | 2.92M |
| Effective Tax Rate | 62.72% |
Stock Price Statistics
The stock price has increased by +12.96% in the last 52 weeks. The beta is 1.13, so Repligen's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +12.96% |
| 50-Day Moving Average | 148.71 |
| 200-Day Moving Average | 134.33 |
| Relative Strength Index (RSI) | 65.57 |
| Average Volume (20 Days) | 815,198 |
Short Selling Information
The latest short interest is 4.09 million, so 7.26% of the outstanding shares have been sold short.
| Short Interest | 4.09M |
| Short Previous Month | 3.32M |
| Short % of Shares Out | 7.26% |
| Short % of Float | 7.75% |
| Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, Repligen had revenue of $707.89 million and earned $1.74 million in profits. Earnings per share was $0.03.
| Revenue | 707.89M |
| Gross Profit | 365.19M |
| Operating Income | 60.06M |
| Pretax Income | 4.66M |
| Net Income | 1.74M |
| EBITDA | 137.22M |
| EBIT | 60.06M |
| Earnings Per Share (EPS) | $0.03 |
Balance Sheet
The company has $748.75 million in cash and $688.87 million in debt, giving a net cash position of $59.88 million or $1.06 per share.
| Cash & Cash Equivalents | 748.75M |
| Total Debt | 688.87M |
| Net Cash | 59.88M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 2.08B |
| Book Value Per Share | 37.01 |
| Working Capital | 965.35M |
Cash Flow
In the last 12 months, operating cash flow was $130.89 million and capital expenditures -$20.91 million, giving a free cash flow of $109.98 million.
| Operating Cash Flow | 130.89M |
| Capital Expenditures | -20.91M |
| Free Cash Flow | 109.98M |
| FCF Per Share | $1.95 |
Margins
Gross margin is 51.59%, with operating and profit margins of 8.48% and 0.25%.
| Gross Margin | 51.59% |
| Operating Margin | 8.48% |
| Pretax Margin | 0.66% |
| Profit Margin | 0.25% |
| EBITDA Margin | 19.38% |
| EBIT Margin | 8.48% |
| FCF Margin | 15.54% |
Dividends & Yields
Repligen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.53% |
| Shareholder Yield | -0.53% |
| Earnings Yield | 0.02% |
| FCF Yield | 1.14% |
Analyst Forecast
The average price target for Repligen is $170.90, which is -0.02% lower than the current price. The consensus rating is "Buy".
| Price Target | $170.90 |
| Price Target Difference | -0.02% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 17.47% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Repligen has an Altman Z-Score of 6.38 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.38 |
| Piotroski F-Score | 6 |